Jon Stonehouse, President & CEO, Director at BioCryst, holds 1.17M shares in BioCryst (Ticker: BCRX), holds 204.09K shares in Bellicum Pharmaceuticals (Ticker: BLCM). Most recently, Jon Stonehouse Bought ― shares of BioCryst on May 15, 2024 for an estimated value of 166.50K.
What is the percentage of profitable transactions made by Jon Stonehouse?
The percentage of profitable transactions made by Jon Stonehouse is 67%.
What is the average return per transaction made by Jon Stonehouse?
The average return per transaction made by Jon Stonehouse is 31.10%.
What stocks does Jon Stonehouse hold?
Jon Stonehouse holds: BCRX, BLCM stocks.
What was Jon Stonehouse’s latest transaction?
Jon Stonehouse latest transaction was an Informative Buy of $166.50K.
What was Jon Stonehouse's most profitable transaction?
Jon Stonehouse’s most profitable transaction was an Informative Buy of BCRX stock on November 18, 2019. The return on the trade was 151.70%.
What is Jon Stonehouse's role in BioCryst?
Jon Stonehouse's role in BioCryst is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.